PACCAR Inc. Common Stock vs Relay Therapeutics Inc. Common Stock — how do they compare? PACCAR Inc. Common Stock trades at $110 (market cap $56.25B), while Relay Therapeutics Inc. Common Stock trades at $17.5 (market cap $3.94B). The key difference: PACCAR Inc. Common Stock is far larger — about 14.3× Relay Therapeutics Inc. Common Stock's market cap, and PACCAR Inc. Common Stock pays a 1.31% dividend while Relay Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold PACCAR Inc. Common Stock for 0 Days and Relay Therapeutics Inc. Common Stock for 0 Days on average.
| PCAR | RLAY | |
|---|---|---|
Market Cap | $56.25B | $3.94B |
Volume | 4,174,670 | 3,432,928 |
Sector | Industrials | Health |
52-Week High | $138.21 | $20.75 |
52-Week Low | $93.00 | $6.03 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $62.11B | $3.06B |
Dividend Yield | 1.31% | — |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
PACCAR designs and manufactures heavy-duty trucks under brands including Peterbilt, Kenworth, and DAF. It also provides parts, financial services, and technology for commercial vehicles.
Read more on PCAR →Relay Therapeutics develops precision medicines for oncology and genetic diseases. Its drug discovery platform studies how protein motion affects drug targets to guide small-molecule medicine design.
Read more on RLAY →